Variante Ômicron

Goiás (Estado). Secretaria de Estado da Saúde; Gerência de Informações Estratégicas em Saúde; Conecta-SUS.
Goiânia; SES-GO; 28 dez. 2021. 1-8 p. ilus, mapa, graf.
Não convencional em Português | LILACS, CONASS, Coleciona SUS - BR, SES-GO | ID: biblio-1353759

Similares

  1. Public health actions to control new SARS-CoV-2 variants.
  2. Genomic surveillance reveals dynamic shifts in the connectivity of COVID-19 epidemics.
  3. The T-cell-directed vaccine BNT162b4 encoding conserved non-spike antigens protects animals from severe SARS-CoV-2 infection.
  4. Population impact of SARS-CoV-2 variants with enhanced transmissibility and/or partial immune escape.
  5. mRNA-1273 or mRNA-Omicron boost in vaccinated macaques elicits similar B cell expansion, neutralizing responses, and protection from Omicron.
  6. Antibody escape of SARS-CoV-2 Omicron BA.4 and BA.5 from vaccine and BA.1 serum.
  7. Neutralizing immunity in vaccine breakthrough infections from the SARS-CoV-2 Omicron and Delta variants.
  8. Targeted isolation of diverse human protective broadly neutralizing antibodies against SARS-like viruses.
  9. Early introductions and transmission of SARS-CoV-2 variant B.1.1.7 in the United States.
  10. Immune imprinting, breadth of variant recognition, and germinal center response in human SARS-CoV-2 infection and vaccination.